Ripretinib is an oral tyrosine kinase inhibitor in the naphthyridine class used to treat adults with advanced gastrointestinal stromal tumors (GIST) who have previously received other therapies. The compound… Read more










Ripretinib is an oral tyrosine kinase inhibitor in the naphthyridine class used to treat adults with advanced gastrointestinal stromal tumors (GIST) who have previously received other therapies. The compound functions by targeting specific KIT and PDGFRA receptors to suppress tumor cell proliferation. Analytical laboratories utilize this category of reference standards, including the active pharmaceutical ingredient, to support method validation and quality control processes. Researchers rely on these materials, including identified impurities and metabolites, for comprehensive impurity profiling to ensure product safety and regulatory compliance. Additionally, stable isotope labelled compounds are available as internal standards for highly sensitive quantitative analysis, such as mass spectrometry, helping to track the drug and its related substances during precise analytical testing procedures.